EW : Edwards Lifesciences stock forecast, predictions, and share price target 2024 - 2025 - 2030 with analysis
| year | Average | Low | High | Change from close on 2024-10-14 |
|---|---|---|---|---|
| 2024 | $63.92 | $62.79 | $65.04 | -8.2% |
| 2025 | $77.98 | $62.94 | $95.34 | 12.0% |
| 2026 | $118.9 | $100.58 | $126.91 | 70.76% |
| 2027 | $128.8 | $127.23 | $129.77 | 84.98% |
| 2028 | $126.5 | $123.24 | $129.39 | 81.68% |
| 2029 | $117.02 | $109.07 | $123.12 | 68.06% |
| 2030 | $122.21 | $108.49 | $129.92 | 75.51% |
| 2031 | $121.26 | $110.69 | $125.46 | 74.16% |
| 2032 | $121.56 | $120.63 | $122.39 | 74.59% |
| 2033 | $121.45 | $108.75 | $135.5 | 74.42% |
| 2034 | $118.79 | $110.87 | $123.03 | 70.6% |
The 39 Wall Street analysts offering Edwards Lifesciences stock forecast in the last 6 months have average price target of
$84.36 with a high forecast of $110.0 and a low forecast of $66.0.
The average Edwards Lifesciences stock forecast represents a 21.15%
increase from the last price of $69.629997253418.
For Edwards Lifesciences stock forecast for 2024, 2 predictions are offered for each month of 2024 with average Edwards Lifesciences stock
forecast of $63.92, a high forecast of $65.04, and a low forecast of $62.79.
The average Edwards Lifesciences stock forecast 2024 represents a -8.2%
decrease from the last price of $69.629997253418.
For Edwards Lifesciences stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Edwards Lifesciences stock
forecast of $77.98, a high forecast of $95.34, and a low forecast of $62.94.
The average Edwards Lifesciences stock forecast 2025 represents a 12.0%
increase from the last price of $69.629997253418.
For Edwards Lifesciences stock forecast for 2027, 12 predictions are offered for each month of 2027 with average Edwards Lifesciences stock
forecast of $128.8, a high forecast of $129.77, and a low forecast of $127.23.
The average Edwards Lifesciences stock forecast 2027 represents a 84.98%
increase from the last price of $69.629997253418.
For Edwards Lifesciences stock forecast for 2029 (5 year), 12 predictions are offered for each month of 2029 with average Edwards Lifesciences stock
forecast of $117.02, a high forecast of $123.12, and a low forecast of $109.07.
The average Edwards Lifesciences stock forecast 2029 represents a 68.06%
increase from the last price of $69.629997253418.
For Edwards Lifesciences stock forecast 2030, 12 predictions are offered for each month of 2030 with average Edwards Lifesciences stock
forecast of $122.21, a high forecast of $129.92, and a low forecast of $108.49.
The average Edwards Lifesciences stock forecast 2030 represents a 75.51%
increase from the last price of $69.629997253418.
For Edwards Lifesciences stock forecast for 2034 (10 year), 10 predictions are offered for each month of 2034 with average Edwards Lifesciences stock
forecast of $118.79, a high forecast of $123.03, and a low forecast of $110.87.
The average Edwards Lifesciences stock forecast 2034 represents a 70.6%
increase from the last price of $69.629997253418.
Please, see more forecasts below.
EW : Edwards Lifesciences stock forecast by Wall Street Analysts
The average Edwards Lifesciences stock forecast from last 6 month is $84.36, and this show a -9.71% decrease in average from the prior price target of the each prediction. Also, this average forecast of $84.36 represents a -0.46% decrease from the past average forecast of $84.75, 6 months ago from 24 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2024-10-11 | Morgan Stanley | $70 | Equal-Weight | |
| 2024-10-08 | RBC Capital | $85.00 | $75.0000 | Outperform |
| 2024-10-07 | Canaccord Genuity | $77.00 | $66.0000 | Hold |
| 2024-10-01 | Citigroup | $83.0000 | $77.0000 | Buy |
| 2024-10-01 | Evercore ISI Group | $76.00 | $70 | In-Line |
| 2024-09-18 | Jefferies | $85.0000 | $70.0000 | Hold |
| 2024-09-13 | Truist Securities | $82.00 | $71 | Hold |
| 2024-09-12 | Oppenheimer | $90.00 | $90 | Outperform |
| 2024-09-10 | UBS | $90.0000 | $75.0000 | Neutral |
| 2024-09-09 | Wells Fargo | $90.00 | $80.0000 | Overweight |
| 2024-09-09 | Barclays | $90.00 | $80.0000 | Overweight |
| 2024-07-29 | Wolfe Research | Peer Perform | ||
| 2024-07-26 | Goldman Sachs | $107.00 | $91 | Buy |
| 2024-07-26 | Barclays | $101.00 | $90.0000 | Overweight |
| 2024-07-25 | JP Morgan | $105.0000 | $72.0000 | Neutral |
| 2024-07-25 | TD Cowen | $100.0000 | $70.0000 | Hold |
| 2024-07-25 | Wells Fargo | $99.00 | $90.0000 | Overweight |
| 2024-07-25 | Evercore ISI Group | $91.00 | $76 | In-Line |
| 2024-07-25 | Deutsche Bank | $103.00 | $85 | Buy |
| 2024-07-25 | RBC Capital | $101.00 | $85 | Outperform |
| 2024-07-25 | Truist Securities | $110.00 | $82 | Hold |
| 2024-07-25 | Stifel | $85.00 | $70 | Hold |
| 2024-07-25 | Oppenheimer | $100.00 | $90 | Outperform |
| 2024-07-25 | Canaccord Genuity | $85.00 | $77.0000 | Hold |
| 2024-07-25 | Piper Sandler | $88.00 | $73 | Neutral |
| 2024-07-25 | B of A Securities | $105.0000 | $75 | Neutral |
| 2024-07-25 | Baird | $102.0000 | $70 | Neutral |
| 2024-07-16 | Truist Securities | $105.0000 | $110 | Buy |
| 2024-07-10 | Citigroup | $105.00 | $106.0000 | Buy |
| 2024-07-02 | Evercore ISI Group | $89.00 | $91 | In-Line |
| 2024-05-30 | Goldman Sachs | $107.0000 | Buy | |
| 2024-05-22 | Citigroup | $98.00 | $105.0000 | Buy |
| 2024-05-14 | Deutsche Bank | $86.0000 | $103 | Buy |
| 2024-05-07 | Barclays | $100.0000 | $101.0000 | Overweight |
| 2024-04-26 | Canaccord Genuity | $86.0000 | $85.0000 | Hold |
| 2024-04-26 | Piper Sandler | $85.0000 | $88 | Neutral |
| 2024-04-26 | Stifel | $83.00 | $85 | Hold |
| 2024-04-26 | Evercore ISI Group | $92.00 | $89 | In-Line |
| 2024-04-26 | Wells Fargo | $94.00 | $99 | Overweight |
| 2024-04-15 | RBC Capital | $95.00 | $101.0000 | Outperform |
| 2024-04-11 | Mizuho | $95.00 | $105 | Buy |
| 2024-04-04 | Evercore ISI Group | $86.0000 | $92 | In-Line |
| 2024-04-03 | Citigroup | $90.0000 | $98.0000 | Neutral |
| 2024-03-26 | OTR Global | Positive | ||
| 2024-03-21 | Morgan Stanley | $95.00 | $103 | Overweight |
| 2024-03-18 | Oppenheimer | $93.0000 | $100 | Outperform |
| 2024-03-07 | B of A Securities | Buy | ||
| 2024-02-07 | RBC Capital | $82.00 | $95.0000 | Outperform |
| 2024-02-07 | Morgan Stanley | $80.00 | $95 | Overweight |
| 2024-02-07 | Mizuho | $85.00 | $95 | Buy |
| 2024-02-07 | Stifel | $70.00 | $83 | Hold |
| 2024-02-02 | Wells Fargo | $94.0000 | Overweight | |
| 2024-01-12 | RBC Capital | $80.0000 | $82 | Outperform |
| 2024-01-04 | Evercore ISI Group | $80.0000 | $77.0000 | In-Line |
| 2023-12-22 | Truist Securities | $78.00 | $84 | Buy |
| 2023-12-11 | Citigroup | Neutral | ||
| 2023-12-11 | Truist Securities | $76.00 | $78.0000 | Buy |
| 2023-12-04 | Morgan Stanley | $102.00 | $80 | Overweight |
| 2023-11-28 | Wolfe Research | $57.0000 | Underperform | |
| 2023-10-26 | Stifel | $87.00 | $70.0000 | Hold |
| 2023-10-26 | Mizuho | $90.0000 | $85.0000 | Buy |
| 2023-10-26 | Truist Securities | $83.0000 | $76.0000 | Buy |
| 2023-10-26 | RBC Capital | $86.0000 | $82.0000 | Outperform |
| 2023-10-26 | Piper Sandler | $83.00 | $68.0000 | Neutral |
| 2023-10-26 | Citigroup | $94.00 | $85.0000 | Buy |
| 2023-10-26 | Wells Fargo | $88.0000 | $75.0000 | Equal-Weight |
| 2023-10-16 | Leerink Partners | $75.0000 | Market Perform |
Edwards Lifesciences stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2024-10-16 | $72.90 | 4.70% |
| 2024-10-17 | $72.76 | -0.19% |
| 2024-10-18 | $74.34 | 2.17% |
| 2024-10-21 | $75.08 | 0.99% |
| 2024-10-22 | $75.38 | 0.39% |
EW : Long term Edwards Lifesciences stock forecast for 2024 - 2025 - 2030
Forecast for 2024 Nov. is $65.04 , for 2025 Oct. is $87.08 , for 2028 Oct. is $124.04 , for 2029 Oct. is $114.16 , for 2033 Oct. is $108.75 , and for 2034 Oct. is $110.87.
EW : Edwards Lifesciences stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Nov. | $65.04 | -6.59% |
| 2024 Dec. | $62.79 | -3.46% |
EW : Edwards Lifesciences stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $62.94 | 0.23% |
| 2025 Feb. | $64.92 | 3.14% |
| 2025 Mar. | $67.82 | 4.47% |
| 2025 Apr. | $70.84 | 4.46% |
| 2025 May. | $73.68 | 4.00% |
| 2025 Jun. | $76.47 | 3.79% |
| 2025 Jul. | $79.40 | 3.82% |
| 2025 Aug. | $82.11 | 3.42% |
| 2025 Sep. | $84.51 | 2.92% |
| 2025 Oct. | $87.08 | 3.03% |
| 2025 Nov. | $90.70 | 4.16% |
| 2025 Dec. | $95.34 | 5.12% |
EW : Edwards Lifesciences stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $100.58 | 5.49% |
| 2026 Feb. | $105.82 | 5.21% |
| 2026 Mar. | $110.70 | 4.61% |
| 2026 Apr. | $114.98 | 3.87% |
| 2026 May. | $118.50 | 3.06% |
| 2026 Jun. | $121.30 | 2.37% |
| 2026 Jul. | $123.46 | 1.78% |
| 2026 Aug. | $125.02 | 1.27% |
| 2026 Sep. | $126.07 | 0.83% |
| 2026 Oct. | $126.62 | 0.44% |
| 2026 Nov. | $126.83 | 0.17% |
| 2026 Dec. | $126.91 | 0.07% |
EW : Edwards Lifesciences stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $127.23 | 0.25% |
| 2027 Feb. | $127.60 | 0.30% |
| 2027 Mar. | $127.97 | 0.29% |
| 2027 Apr. | $128.27 | 0.24% |
| 2027 May. | $128.39 | 0.09% |
| 2027 Jun. | $128.90 | 0.40% |
| 2027 Jul. | $129.19 | 0.22% |
| 2027 Aug. | $129.42 | 0.17% |
| 2027 Sep. | $129.63 | 0.17% |
| 2027 Oct. | $129.77 | 0.10% |
| 2027 Nov. | $129.73 | -0.03% |
| 2027 Dec. | $129.53 | -0.15% |
EW : Edwards Lifesciences stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $129.39 | -0.11% |
| 2028 Feb. | $129.14 | -0.19% |
| 2028 Mar. | $128.75 | -0.30% |
| 2028 Apr. | $128.26 | -0.39% |
| 2028 May. | $127.62 | -0.49% |
| 2028 Jun. | $127.09 | -0.42% |
| 2028 Jul. | $126.43 | -0.52% |
| 2028 Aug. | $125.62 | -0.64% |
| 2028 Sep. | $124.77 | -0.68% |
| 2028 Oct. | $124.04 | -0.59% |
| 2028 Nov. | $123.65 | -0.31% |
| 2028 Dec. | $123.24 | -0.33% |
EW : Edwards Lifesciences stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $122.70 | -0.44% |
| 2029 Feb. | $121.97 | -0.60% |
| 2029 Mar. | $120.98 | -0.81% |
| 2029 Apr. | $119.71 | -1.06% |
| 2029 May. | $117.89 | -1.52% |
| 2029 Jun. | $114.90 | -2.54% |
| 2029 Jul. | $110.75 | -3.61% |
| 2029 Aug. | $109.07 | -1.51% |
| 2029 Sep. | $110.02 | 0.87% |
| 2029 Oct. | $114.16 | 3.76% |
| 2029 Nov. | $119.00 | 4.24% |
| 2029 Dec. | $123.12 | 3.46% |
EW : Edwards Lifesciences stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $126.39 | 2.66% |
| 2030 Feb. | $128.56 | 1.72% |
| 2030 Mar. | $129.15 | 0.45% |
| 2030 Apr. | $129.83 | 0.53% |
| 2030 May. | $129.92 | 0.07% |
| 2030 Jun. | $128.97 | -0.73% |
| 2030 Jul. | $125.72 | -2.52% |
| 2030 Aug. | $121.15 | -3.64% |
| 2030 Sep. | $116.50 | -3.84% |
| 2030 Oct. | $112.48 | -3.45% |
| 2030 Nov. | $109.30 | -2.83% |
| 2030 Dec. | $108.49 | -0.74% |
EW : Edwards Lifesciences stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $110.69 | 2.03% |
| 2031 Feb. | $113.86 | 2.86% |
| 2031 Mar. | $117.45 | 3.16% |
| 2031 Apr. | $120.82 | 2.87% |
| 2031 May. | $123.55 | 2.26% |
| 2031 Jun. | $125.17 | 1.31% |
| 2031 Jul. | $125.46 | 0.24% |
| 2031 Aug. | $124.99 | -0.38% |
| 2031 Sep. | $124.22 | -0.62% |
| 2031 Oct. | $123.44 | -0.63% |
| 2031 Nov. | $122.89 | -0.45% |
| 2031 Dec. | $122.64 | -0.20% |
EW : Edwards Lifesciences stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $122.39 | -0.20% |
| 2032 Feb. | $121.95 | -0.35% |
| 2032 Mar. | $121.82 | -0.11% |
| 2032 Apr. | $121.90 | 0.07% |
| 2032 May. | $122.04 | 0.11% |
| 2032 Jun. | $122.04 | 0.01% |
| 2032 Jul. | $121.82 | -0.19% |
| 2032 Aug. | $121.37 | -0.37% |
| 2032 Sep. | $120.96 | -0.34% |
| 2032 Oct. | $120.63 | -0.27% |
| 2032 Nov. | $120.66 | 0.02% |
| 2032 Dec. | $121.22 | 0.46% |
EW : Edwards Lifesciences stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $122.37 | 0.95% |
| 2033 Feb. | $123.73 | 1.12% |
| 2033 Mar. | $125.47 | 1.41% |
| 2033 Apr. | $131.17 | 4.54% |
| 2033 May. | $135.50 | 3.30% |
| 2033 Jun. | $131.04 | -3.29% |
| 2033 Jul. | $122.55 | -6.48% |
| 2033 Aug. | $115.85 | -5.47% |
| 2033 Sep. | $111.47 | -3.78% |
| 2033 Oct. | $108.75 | -2.44% |
| 2033 Nov. | $111.93 | 2.92% |
| 2033 Dec. | $117.58 | 5.05% |
EW : Edwards Lifesciences stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $120.01 | 2.07% |
| 2034 Feb. | $122.01 | 1.66% |
| 2034 Mar. | $123.03 | 0.84% |
| 2034 Apr. | $122.99 | -0.03% |
| 2034 May. | $122.04 | -0.77% |
| 2034 Jun. | $120.40 | -1.35% |
| 2034 Jul. | $118.18 | -1.84% |
| 2034 Aug. | $115.51 | -2.25% |
| 2034 Sep. | $112.87 | -2.29% |
| 2034 Oct. | $110.87 | -1.77% |
Frequently Asked Questions about Edwards Lifesciences stock forecast
Is Edwards Lifesciences a good long term stock?
From Edwards Lifesciences stock forecast , Edwards Lifesciences (EW) stock cannot be a good investment choice. According to AIPickup, the Edwards Lifesciences stock price forecast for 2024 Nov. is $65.044409447417 From Edwards Lifesciences stock forecast , Edwards Lifesciences (EW) stock can be a good investment choice. According to AIPickup, the Edwards Lifesciences stock price forecast for 2025 Oct. is $87.0767474363362 From Edwards Lifesciences stock forecast , Edwards Lifesciences (EW) stock can be a good investment choice. According to AIPickup, the Edwards Lifesciences stock price forecast for 2028 Oct. is $124.036882943194 From Edwards Lifesciences stock forecast , Edwards Lifesciences (EW) stock can be a good investment choice. According to AIPickup, the Edwards Lifesciences stock price forecast for 2029 Oct. is $114.159828148356 From Edwards Lifesciences stock forecast , Edwards Lifesciences (EW) stock can be a good investment choice. According to AIPickup, the Edwards Lifesciences stock price forecast for 2033 Oct. is $108.748311475223 From Edwards Lifesciences stock forecast , Edwards Lifesciences (EW) stock can be a good investment choice. According to AIPickup, the Edwards Lifesciences stock price forecast for 2034 Oct. is $110.868842066054
Is Edwards Lifesciences stock overvalued?
Edwards Lifesciences (EW) stock is expected to go UP . Therefore, AIPickup would say that Edwards Lifesciences (EW) stock is NOT overvalued.
Will Edwards Lifesciences stock price go up?
Yes. The Edwards Lifesciences stock price forecast for 2025 Oct. is $87.0767474363362
Is Edwards Lifesciences stock a good buy now?
Since closing price on 2024-10-14 is $69.629997253418 and forecast for 2025 Oct. is $87.08, Edwards Lifesciences stock is a good 1 year investment.
14 Days Historical Data for Edwards Lifesciences stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| EW stock price for 2024-09-25 | $65.41 | $66.51 | $65.09 | $66.82 |
| EW stock price for 2024-09-26 | $65.77 | $65.96 | $64.54 | $66.00 |
| EW stock price for 2024-09-27 | $66.58 | $66.20 | $65.85 | $67.32 |
| EW stock price for 2024-09-30 | $65.99 | $66.18 | $65.20 | $66.75 |
| EW stock price for 2024-10-01 | $65.10 | $66.08 | $64.99 | $66.32 |
| EW stock price for 2024-10-02 | $65.15 | $64.91 | $64.56 | $65.77 |
| EW stock price for 2024-10-03 | $65.37 | $64.86 | $64.08 | $66.04 |
| EW stock price for 2024-10-04 | $65.49 | $65.79 | $64.05 | $65.83 |
| EW stock price for 2024-10-07 | $64.54 | $65.05 | $64.01 | $65.19 |
| EW stock price for 2024-10-08 | $68.54 | $64.82 | $64.51 | $68.89 |
| EW stock price for 2024-10-09 | $68.02 | $68.72 | $67.75 | $69.02 |
| EW stock price for 2024-10-10 | $68.26 | $67.65 | $67.59 | $68.52 |
| EW stock price for 2024-10-11 | $68.13 | $68.44 | $67.96 | $69.64 |
| EW stock price for 2024-10-14 | $69.63 | $68.71 | $68.37 | $69.79 |